Beam Therapeutics Earnings
NASDAQ: BEAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 12:47 PM ET
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.16
Beam Therapeutics earnings summary
Beam Therapeutics is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-1.16. In its most recent report on Aug 4, 2026 (Q2 2026), BEAM posted EPS of $-1.18. Revenue for the quarter was $490,000.
Across the last 16 reports, BEAM shares moved an average of 8.3% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
BEAM earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $-1.18 | — | -2.7% |
| May 7, 2026 | — | $-0.91 | — | -13.6% |
| Feb 24, 2026 | — | $2.52 | — | -6.7% |
| Nov 4, 2025 | — | $-1.10 | — | -2.2% |
| Aug 5, 2025 | — | $-1.00 | — | +1.1% |
| May 6, 2025 | — | $-1.23 | — | +2.8% |
| Feb 25, 2025 | — | $-1.09 | — | +8.1% |
| Nov 5, 2024 | — | $-1.17 | — | -11.1% |
| Aug 6, 2024 | — | $-1.11 | — | -0.1% |
| May 7, 2024 | — | $-1.21 | — | +15.8% |
| Feb 27, 2024 | — | $1.91 | — | -5.8% |
| Nov 8, 2023 | — | $-1.22 | — | +24.0% |
| Aug 8, 2023 | — | $-1.08 | — | -8.6% |
| May 10, 2023 | — | $-1.33 | — | +3.6% |
| Feb 28, 2023 | — | $-0.54 | — | -17.8% |
| Nov 7, 2022 | — | $-1.56 | — | -8.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.